Real-time monitoring of physiological pH in living systems is essential for accurate disease evaluation and therapeutic guidance. However, conventional pH-responsive probes typically operate through monotonic activation and lack window selectivity, limiting their capacity to report further microenvironmental changes after crossing the activation threshold. Here, we report a NIR-II molecularly engineered band-pass pH (BPpH) sensing strategy that exhibits a non-monotonic “off-on-off” fluorescence response. By integrating an acid-responsive spirolactam switch with an alkaline-sensitive phenolic regulator, the BPpH probes enable window-restricted signal output within a defined pH range. BPpH-3 displays fluorescence activation from pH 3.6 to 5.2 and deactivation from pH 5.2 to 8.0, affording dual apparent pKa values of 4.16 and 7.42 and establishing a response window. Unlike conventional monotonic turn-on probes, this band-pass response enables continuous tracking of pH changes across the therapeutic process, and BPpH-3 further enables dynamic evaluation of therapeutic efficacy in a skin inflammation model, allowing timely assessment of treatment progression and dosing sufficiency. Moreover, its window-constrained response mitigates signal over-amplification under extreme acidification, facilitating improved tumor margin delineation for precision resection under NIR-II imaging guidance. The band-pass sensing strategy presented here provides a transferable framework for window-regulated detection of diverse physiological parameters and holds promise for integration with multiple diagnostic imaging modalities.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: